Compare EFSCP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Enterprise Financial Services Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of 5% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Current Price
| Metric | EFSCP | SNN |
|---|---|---|
| Founded | N/A | 1856 |
| Country | United States | United Kingdom |
| Employees | 1256 | N/A |
| Industry | Major Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 13.9B |
| IPO Year | N/A | 1999 |
| Metric | EFSCP | SNN |
|---|---|---|
| Price | $20.02 | $34.11 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.83 |
| AVG Volume (30 Days) | N/A | ★ 599.2K |
| Earning Date | N/A | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.17% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | N/A | ★ $5,944,000,000.00 |
| Revenue This Year | N/A | $7.71 |
| Revenue Next Year | N/A | $5.23 |
| P/E Ratio | ★ N/A | $60.38 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | N/A | $23.69 |
| 52 Week High | N/A | $38.79 |
| Indicator | EFSCP | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 63.47 | 60.94 |
| Support Level | $19.35 | $32.42 |
| Resistance Level | $20.50 | $34.20 |
| Average True Range (ATR) | 0.31 | 0.41 |
| MACD | 0.08 | 0.18 |
| Stochastic Oscillator | 93.10 | 93.82 |
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.